Drugs / BI 671800
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT01216384 | Oct → Dec 2010 | asthma, perennial allergic rhinitis | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01215773 | Oct → Dec 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT01205373 | Sep → Oct 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02221388 | Feb → Jul 2010 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT01103349 | Apr 2010 → Aug 2011 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 2 | NCT01092143 | Mar 2010 → Mar 2011 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 2 | NCT01090024 | Mar 2010 → Feb 2011 | asthma | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 2 | NCT01007721 | Oct 2009 → Apr 2010 | asthma, seasonal allergic rhinitis | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 671800 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01103349 ↗ |
| Known as | Actimis | ChEMBL registry synonym — accepted as the source's own label CHEMBL551813 ↗ |
| Action | Inhibit | “G protein-coupled receptor 44 antagonist” CHEMBL551813 ↗1“oral CRTH2 antagonist BI 671800” PMID 24332218 ↗ Dec 2013 |
| Modality | Small molecule | — CHEMBL551813 ↗ |
| Route | Oral | “oral CRTH2 antagonist BI 671800” PMID 24332218 ↗ Dec 2013 |
| Target | PTGDR2 | “G protein-coupled receptor 44 antagonist” CHEMBL551813 ↗ |